Complement C7 (C7), a Potential Tumor Suppressor, Is an Immune-Related Prognostic Biomarker in Prostate Cancer (PC).

Front Oncol · 2020 · PMC7477933 · PMID 32984006

Europe PMC DOI

hedged sentence

0.1100

closest p · 2.2× alpha

0.1100

boldest claim

The sentences

showed a trendP = 0.110not close (p > 0.1)

RFS survival analyses showed a trend of worse RFS in PC patients with high immune scores ( P = 0.110, Figure S1B ) or high stromal scores ( P = 0.190, Figure S1D ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.